These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
467 related items for PubMed ID: 21357909
1. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ioannou GN. Ann Intern Med; 2011 Mar 01; 154(5):319-28. PubMed ID: 21357909 [Abstract] [Full Text] [Related]
2. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, Bell B. J Infect Dis; 2010 Jul 15; 202(2):192-201. PubMed ID: 20533878 [Abstract] [Full Text] [Related]
3. Surveillance for acute viral hepatitis - United States, 2007. Daniels D, Grytdal S, Wasley A, Centers for Disease Control and Prevention (CDC). MMWR Surveill Summ; 2009 May 22; 58(3):1-27. PubMed ID: 19478727 [Abstract] [Full Text] [Related]
4. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana. Mahoney FJ, Lawrence M, Scott C, Le Q, Lambert S, Farley TA. Pediatrics; 1995 Dec 22; 96(6):1113-6. PubMed ID: 7491231 [Abstract] [Full Text] [Related]
5. The decline of hepatitis B viral infection in South-Western Saudi Arabia. Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM. Saudi Med J; 2003 Sep 22; 24(9):991-5. PubMed ID: 12973485 [Abstract] [Full Text] [Related]
6. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size. Luo Z, Xie Y, Deng M, Zhou X, Ruan B. Eur J Gastroenterol Hepatol; 2011 Aug 22; 23(8):695-700. PubMed ID: 21617533 [Abstract] [Full Text] [Related]
7. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage. Melo LV, da Silva MA, Calçada Cde O, Cavalcante SR, Souto FJ. Vaccine; 2011 Jul 18; 29(32):5290-3. PubMed ID: 21605613 [Abstract] [Full Text] [Related]
8. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, Yeh CT. Gastroenterology; 2012 Aug 18; 143(2):400-7. PubMed ID: 22580098 [Abstract] [Full Text] [Related]
9. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme. Su FH, Chen JD, Cheng SH, Sung KY, Jeng JJ, Chu FY. J Viral Hepat; 2008 Jan 18; 15(1):14-9. PubMed ID: 18088240 [Abstract] [Full Text] [Related]
10. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005. Cowie B, Karapanagiotidis T, Enriquez A, Kelly H. Aust N Z J Public Health; 2010 Feb 18; 34(1):72-8. PubMed ID: 20920109 [Abstract] [Full Text] [Related]
11. Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan. Chen SM, Kung CM, Yang WJ, Wang HL. J Clin Virol; 2011 Sep 18; 52(1):11-6. PubMed ID: 21767983 [Abstract] [Full Text] [Related]
12. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. Amini S, Mahmoodi MF, Andalibi S, Solati AA. J Trop Med Hyg; 1993 Oct 18; 96(5):277-87. PubMed ID: 8411302 [Abstract] [Full Text] [Related]
13. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect). Azarkeivan A, Karimi G, Shaiegan M, Maghsudlu M, Tabbaroki A. Pediatr Hematol Oncol; 2009 Jun 18; 26(4):195-201. PubMed ID: 19437322 [Abstract] [Full Text] [Related]
14. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination. Zhang L, Xu A, Yan B, Song L, Li M, Xiao Z, Xu Q, Li L. Int J Infect Dis; 2010 Jun 18; 14(6):e483-8. PubMed ID: 19939719 [Abstract] [Full Text] [Related]
15. Minimization of hepatitis B infection by a 25-year universal vaccination program. Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL, Chen DS. J Hepatol; 2012 Oct 18; 57(4):730-5. PubMed ID: 22668640 [Abstract] [Full Text] [Related]
16. Hepatitis B vaccination in children: the Taiwan experience. Ni YH, Chen DS. Pathol Biol (Paris); 2010 Aug 18; 58(4):296-300. PubMed ID: 20116181 [Abstract] [Full Text] [Related]
17. Impact of hepatitis B vaccination among children in Guangdong Province, China. Xiao J, Zhang J, Wu C, Shao X, Peng G, Peng Z, Ma W, Zhang Y, Zheng H. Int J Infect Dis; 2012 Sep 18; 16(9):e692-6. PubMed ID: 22795176 [Abstract] [Full Text] [Related]
18. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012. Roberts H, Kruszon-Moran D, Ly KN, Hughes E, Iqbal K, Jiles RB, Holmberg SD. Hepatology; 2016 Feb 18; 63(2):388-97. PubMed ID: 26251317 [Abstract] [Full Text] [Related]
19. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea. Sanders RC, Lewis D, Dyke T, Alpers MP. P N G Med J; 1992 Sep 18; 35(3):197-201. PubMed ID: 1296422 [Abstract] [Full Text] [Related]
20. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab. Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C. Am J Gastroenterol; 2012 Jan 18; 107(1):133-8. PubMed ID: 21876562 [Abstract] [Full Text] [Related] Page: [Next] [New Search]